Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

GeneDx Holdings (WGS) Assets Average (2020 - 2025)

GeneDx Holdings (WGS) has disclosed Assets Average for 5 consecutive years, with $391.8 million as the latest value for Q2 2024.

  • On a quarterly basis, Assets Average fell 23.3% to $391.8 million in Q2 2024 year-over-year; TTM through Jun 2024 was $391.8 million, a 23.3% decrease, with the full-year FY2025 number at $471.5 million, up 12.52% from a year prior.
  • Assets Average was $391.8 million for Q2 2024 at GeneDx Holdings, down from $406.6 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $881.1 million in Q3 2022 to a low of $197.4 million in Q2 2021.
  • A 5-year average of $482.9 million and a median of $446.8 million in 2023 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: soared 267.49% in 2022, then plummeted 49.29% in 2023.
  • GeneDx Holdings' Assets Average stood at $347.9 million in 2020, then surged by 66.33% to $578.7 million in 2021, then grew by 14.04% to $660.0 million in 2022, then tumbled by 36.66% to $418.0 million in 2023, then dropped by 6.27% to $391.8 million in 2024.
  • Per Business Quant, the three most recent readings for WGS's Assets Average are $391.8 million (Q2 2024), $406.6 million (Q1 2024), and $418.0 million (Q4 2023).